Editorial: Inflammatory Bowel Disease Risk Reduction After Migration - Are Early Life Events Important?

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14034
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: Migration Studies to Determine Risk and Cause of Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: Treating Strictures in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: Anxiety and Depression in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: Treating Strictures in Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Inflammatory Bowel Disease

Annual Review of Immunology
AllergyImmunology
2010English

Recent Advance in Very Early Onset Inflammatory Bowel Disease

Intestinal Research
Gastroenterology
2019English

Indigenous Amoebiasis: An Important Differential Diagnosis of Chronic Inflammatory Bowel Disease.

BMJ
1984English

Inflammatory Bowel Disease

American Journal of Gastroenterology
HepatologyGastroenterology
2007English

Editorial: Weighing the Global Risk of Cancer With Thiopurines in Inflammatory Bowel Disease-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy